ARUP Laboratories Expands AI Tool for Parasitology Screening
ARUP Laboratories has expanded its AI-augmented screening tool to include wet-mount slides, announced in a press release. This expansion makes ARUP the first laboratory to apply AI-augmented screening to the entire ova and parasite testing process.
The AI tool enhances the detection of human gastrointestinal parasites by minimizing human error and identifying ova and parasites that might otherwise be missed. This improvement in sensitivity and diagnostic yield is expected to enhance clinical diagnoses and treatment outcomes for affected patients.
The AI-augmented screening tool, developed in partnership with Techcyte, uses scanned images to screen and eliminate negative specimens, allowing laboratory staff to focus on identifying positive specimens. This approach reduces ergonomic stress, decreases turnaround time, and increases laboratory capacity, ultimately improving patient care.
Since its initial launch in 2019, the AI tool has shown a five-fold increase in detection limits and nearly doubled the positivity rate, setting a new standard for ova and parasite testing.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
NYU Langone Tests AI Tool to Fill Radiology Training Gaps
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Lunai Bioworks Tests AI Chemical Risk Screening Model
Danaher Plans AI Autonomous Lab for Antibody Research
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Daily AI Brief: the AI news that matters, in your inbox.